Carinopharm GmbH was founded on 22 June 1999 and is based in Eime; the company develops, distributes and markets pharmaceuticals primarily in the therapeutic areas of cardiology, intensive care and emergency medicine for the hospital market. Its strategic focus includes expanding market share in the German hospital market, growing export business and broadening the product portfolio by adding new products. Carinopharm continuously invests in development projects for generic preparations and operated two active development projects in the 2024 financial year. The company holds a 100% stake in INCA Pharm S.r.l. (Frosinone, Italy); INCA's equity amounted to €533k and its profit for 2024 was €123k.
Vertrieb, Import und Export und das Inverkehrbringen von pharmazeutischen Produkten sowie der Handel mit diesen, der Kauf und Verkauf von Arzneimittelzulassungen und die Beteiligung an anderen Unternehmen mit ähnlichem Geschäftszweck
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Hildesheim Local Court, HRB 15305 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) Hildesheim Local Court, HRB 15305 (as of 9 October 2026)
Source: German Commercial Register (Handelsregister) Hildesheim Local Court, HRB 15305 (as of 9 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Hildesheim Local Court, HRB 15305 (as of 9 October 2026)
Sign in to view detailed salary and cost trends.
